Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesEVE Health Group Limited

EVE Health Group Limited

Consumer Defensive Packaged Foods
PortfolioPortfolio WatchlistWatchlist
Company price
0.013 AUD 0.00(0%)
Last update at 2026-11-12T01:02:00Z
VOLUME
115000
Market Cap
4.23M

Momentum Score

…

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property). Its lead product is the Dyspro, a formulation developed to address dysmenorrhoea and Endometriosis Pain; and Libbo, an oral dissolving film for erectile dysfunction. The company also develops Apixaban to treat anticoagulation. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

EVE Health Group Limited is an Australian-listed health services company that, based on public disclosures, appears focused on primary care and digital health delivery. Long-term growth may be supported by ageing populations, higher demand for accessible outpatient and telehealth services, and potential scalability of digital platforms, which could make the company attractive to investors seeking exposure to healthcare delivery trends.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
1.15M
Revenue Per Share
0.00
Gross Profit TTM
0.53M
Debt / Equity
0.06
ROE
-50.43%
Net Debt
-1.24M
ROCE
-48.15%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -1.89M -1.45M -1.55M -2.35M -5.37M
Net income -1.89M -1.58M -1.90M -3.07M -5.37M
Selling general administrative - 0.95M 0.99M 1.33M 2.24M
Selling and marketing expenses - 0.95M 1.13M 1.26M 2.01M
Gross profit -0.11M 0.82M 0.88M 0.83M 0.98M
Reconciled depreciation - 0.00M 0.01M 0.17M 0.33M
Ebit -1.90M -1.43M -1.51M -2.26M -4.54M
Ebitda -1.77M -1.43M -1.51M -2.09M -4.22M
Depreciation and amortization 0.13M 0.00M 0.01M 0.17M 0.33M
Operating income -1.90M -1.43M -1.54M -2.34M -4.22M
Other operating expenses 3.05M 3.16M 3.68M 1.67M 4.58M
Interest expense 0.00M 0.03M 0.03M - 0.01M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.00M 0.03M 0.02M 0.01M
Net interest income - -0.03M -0.03M 0.00M -4.00M
Extraordinary items - -0.13M -0.35M 0.72M 0.25M
Income tax expense - - 0.35M 0.81M -0.22M
Total revenue 1.15M 1.73M 2.13M 2.33M 2.39M
Total operating expenses 1.79M 2.25M 2.42M 3.18M 5.31M
Cost of revenue 1.26M 0.91M 1.26M 1.50M 1.41M
Total other income expense net 0.01M -0.02M -0.01M 0.00M -1.05M
Discontinued operations - - - -1.69M -0.25M
Net income from continuing ops - -1.45M -1.55M -2.35M -5.37M
Net income applicable to common shares - -1.58M -1.90M -1.63M -5.37M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 4.28M 4.12M 2.52M 5.11M 8.07M
Intangible assets 2.86M 3.00M - 0.00M 0.10M
Other current assets - - 2.20M 4.18M 0.08M
Total liab 0.33M 0.57M 1.30M 1.01M 1.14M
Total stockholder equity 3.95M 3.55M 1.22M 4.10M 6.93M
Other current liab 0.08M - 0.96M 0.75M 0.40M
Common stock 41.94M - 35.83M 35.83M 35.62M
Capital stock - 39.74M - 35.83M 35.62M
Retained earnings -38.08M -36.19M -34.80M -32.17M -29.10M
Good will - - - - 0.00M
Other assets - - - - 0.37M
Cash 1.24M 0.90M 0.11M 0.19M 1.10M
Cash and equivalents - - - - 1.10M
Total current liabilities 0.33M 0.57M 1.30M 1.01M 0.74M
Current deferred revenue - - - -0.52M -0.10M
Net debt -1.24M - -0.03M 0.32M -0.61M
Short term debt - - 0.07M 0.51M 0.10M
Short long term debt - 0.09M - 0.51M 0.05M
Short long term debt total - - 0.07M 0.51M 0.49M
Other stockholder equity - - - -4.99M -8.81M
Property plant equipment - - - 0.01M 4.53M
Total current assets 1.41M 1.13M 2.52M 5.10M 2.72M
Long term investments - - - - 0.36M
Net tangible assets - - - 3.12M 6.84M
Short term investments - - - - 0.00M
Net receivables 0.06M 0.04M 0.08M 0.12M 0.25M
Long term debt - - - 0.00M 0.39M
Inventory 0.11M 0.18M 0.14M 0.60M 1.36M
Accounts payable 0.25M 0.26M 0.26M 0.26M 0.34M
Accumulated other comprehensive income 0.09M - 0.19M 0.43M 0.42M
Non currrent assets other - - 0.00M - -4.99M
Non current assets total 2.86M 3.00M 0.00M 0.01M 5.36M
Capital lease obligations - - - 0.00M 0.05M
Long term debt total - - - 0.00M 0.40M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - 2.13M 0.87M 0.50M -0.03M
Change to liabilities - - - -0.05M -0.07M
Total cashflows from investing activities -0.00M 2.13M 0.87M 0.50M -0.03M
Net borrowings - -0.63M 0.15M 0.02M -0.27M
Total cash from financing activities 2.08M 0.28M 0.15M 0.24M 1.74M
Net income -1.89M -1.58M -1.55M -4.04M -5.37M
Change in cash 0.33M 0.80M -0.09M -0.91M -2.06M
Begin period cash flow 0.90M 0.11M 0.19M 1.10M 3.16M
End period cash flow 1.24M 0.90M 0.11M 0.19M 1.10M
Total cash from operating activities -1.74M -1.62M -1.11M -1.65M -3.77M
Issuance of capital stock - 1.03M - 0.22M 2.14M
Depreciation 0.13M - 0.01M 0.23M 0.33M
Other cashflows from investing activities - 2.13M 0.84M 0.50M -
Dividends paid - - - 0.12M 0.11M
Change to inventory 0.07M -0.04M 0.46M 0.61M -0.25M
Change to account receivables -0.02M 0.03M 0.04M 0.07M 0.10M
Sale purchase of stock - -0.12M 0.00M -0.01M -0.14M
Other cashflows from financing activities - -0.12M -0.00M 0.19M 0.11M
Change to netincome - - - 1.53M 1.50M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.03M
Change in working capital -0.10M -0.13M 0.61M 0.68M -0.15M
Stock based compensation - - - 0.02M 0.11M
Other non cash items 0.12M -1.49M -0.17M 2.16M 1.27M
Free cash flow -1.74M -1.62M -1.11M -1.65M -3.80M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
EVE
EVE Health Group Limited		 -
-%		 0.01 - - 3.67 1.07 2.89 -1.05
A2M
The a2 Milk Company Ltd		 -0.07
0.96%		 7.19 29.04 28.74 2.68 5.94 2.85 17.82
BGA
Bega Cheese Ltd		 -0.02
0.30%		 6.74 35.61 22.94 0.52 1.93 0.60 11.82
CBO
Cobram Estate Olives Ltd		 -0.06
2.26%		 2.59 - - 4.79 2.48 6.63 185.44
RIC
Ridley Corporation Ltd		 0.02
0.74%		 2.74 38.29 13.42 0.35 2.01 0.53 4.50

Profile*

EVE Health Group Limited

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property). Its lead product is the Dyspro, a formulation developed to address dysmenorrhoea and Endometriosis Pain; and Libbo, an oral dissolving film for erectile dysfunction. The company also develops Apixaban to treat anticoagulation. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

245 Churchill Avenue, Subiaco, WA, Australia, 6008

61 8 6465 5500

https://www.evehealthgroup.com.au

Name Title Year Born
Mr. Gregory William Fry MD & CEO 1966
Mr. Benedict James Rohr Chief Operating Officer NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Sec. NA
Ms. Elizabeth Caiulo Admin. Professional NA
Ms. Beck Howe Sales & Marketing Professional NA
Ms. Stephanie Yip Marketing Director NA
Ms. Robyn Ingersole Chief Exec. Officer of Naturally Australian Products NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Secretary NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Secretary NA
Mr. Steven Luke Jackson BEc, C.P.A., CPA CFO & Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…